Amends the Defense Production Act to include biotechnology in "prohibited technology" and "notifiable technology" definitions.

The Biotech Investment National Security Act of 2026 amends the Defense Production Act of 1950 to include biotechnology in the definitions of "prohibited technology" and "notifiable technology." This bill defines biotechnology as the research, development, manufacturing, or commercialization of pharmaceutical products, biological products, and therapeutic compounds. It aims to prevent U.S. capital and intellectual property from accelerating China's dominance in the pharmaceutical innovation supply chain.

Amends the Defense Production Act to include biotechnology in "prohibited technology" and "notifiable technology" definitions.

The Biotech Investment National Security Act of 2026 amends the Defense Production Act of 1950 to include biotechnology in the definitions of "prohibited technology" and "notifiable technology." This bill defines biotechnology as the research, development, manufacturing, or commercialization of pharmaceutical products, biological products, and therapeutic compounds. It aims to prevent U.S. capital and intellectual property from accelerating China's dominance in the pharmaceutical innovation supply chain.